Search results
Tower Research Capital LLC TRC Acquires 26,847 Shares of Illumina, Inc. (NASDAQ:ILMN)
ETF DAILY NEWS· 5 hours agoTower Research Capital LLC TRC lifted its holdings in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 364.9% during the fourth quarter, according ...
Illumina to spin off early cancer detection test maker Grail after ill-fated $8 billion acquisition...
The Business Journals· 2 days agoMore than three years after planning its own initial public offering, early cancer detection test...
Illumina shares hold rating from Jefferies By Investing.com
Investing.com· 4 days agoOn Monday, Jefferies began covering Illumina, Inc. (NASDAQ:ILMN), a leading company in...
Illumina's board approves to spin off Grail in June By Reuters
Investing.com· 4 days agoShareholders will receive one common share of Grail for every six shares of Illumina (NASDAQ:ILMN),...
Illumina sets date for GRAIL spin-off and share distribution By Investing.com
Investing.com· 4 days agoIllumina Inc. (NASDAQ:ILMN), a global leader in DNA sequencing technologies, has announced the...
Grail to become an Illumina spinout once again, as divestment plan moves forward
FierceBiotech· 4 days agoThe company’s board of directors has approved the plan for Grail to join the Nasdaq, under the...
Illumina to Spin off Grail by Issuing Shares to Investors, Will Keep 14.5 Percent
GenomeWeb News· 4 days agoIllumina will issue one share of Grail to investors for every six shares of Illumina stock and will retain a 14.5 percent stake in Grail. Investors will ...
Illumina (NASDAQ:ILMN) Now Covered by Analysts at Jefferies Financial Group
ETF DAILY NEWS· 4 days agoEquities research analysts at Jefferies Financial Group initiated coverage on shares of Illumina (NASDAQ:ILMN – Get Free Report) in a research report issued ...
Thomas Kean Jr. makes moves in Illumina and Nike stocks By Investing.com
Investing.com· 7 days agoIn a recent congressional trade report, Thomas Kean Jr., representing New Jersey's 7th congressional...
Illumina board approves Grail spinoff
MedTech Dive via Yahoo Finance· 3 days agoLeerink Partners analyst Puneet Souda said Grail, with a cash burn of $532 million in 2023, is likely to remain “a cautionary tale in diagnostics for...